Recipient sensitization against donor cells in pre- and/or posttransplantation sera is inversely correlated with graft survival.
Sumitran
S
S
Department of Clinical Immunology, Huddinge University Hospital, Sweden.
Forsberg
I
I
Lindholm
A
A
Lundgren
G
G
Möller
E
E
D000888:Antibodies, Anti-Idiotypic / Q000032:analysis*; D001402:B-Lymphocytes / Q000276:immunology*; D003524:Cyclosporins / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000032:analysis; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006801:Humans; D007114:Immunization; D016030:Kidney Transplantation / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D000888:Antibodies, Anti-Idiotypic; D003524:Cyclosporins; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II